Position in FDMT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$369,550 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Derivatives in FDMT
reported options exposure · as of Jun 30, 2026CallValue
$207,480
CallShares
15,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,363,981,840 across 291 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in FDMT
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $207,480 | 15,600 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $369,550 | 39,694 | Shares | Defined | 2026-05-12 | |
| 2026-03-31 | $576,289 | 61,900 | Put | Defined | 2026-05-12 | |
| 2026-03-31 | $159,201 | 17,100 | Call | Defined | 2026-05-12 | |
| 2025-12-31 | $121,500 | 16,200 | Call | Defined | 2026-02-12 | |
| 2025-12-31 | $1,686,771 | 224,903 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,015,989 | 116,915 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $212,905 | 24,500 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $706,283 | 190,373 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $455,038 | 140,879 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $1,174,288 | 210,824 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,572,983 | 145,512 | Shares | Defined | 2024-11-15 | |
| 2024-09-30 | $637,790 | 59,000 | Put | Defined | 2024-11-15 | |
| 2024-06-30 | $2,802,689 | 133,525 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $940,219 | 29,511 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $516,527 | 25,495 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $597,341 | 46,924 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $755,018 | 41,783 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $806,355 | 36,306 | Shares | Defined | 2023-02-15 | |
| No filing history on record for this holder in this stock. | ||||||